T 1309/08 (Exendins/AMYLIN PHARMACEUTICALS, INC.) of 22.05.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T130908.20120522
- Date of decision
- 22 May 2012
- Case number
- T 1309/08
- Petition for review of
- -
- Application number
- 01900978.6
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of exendins and agonists thereof for the treatment of hypertriglyceridemia
- Applicant name
- AMYLIN PHARMACEUTICALS, INC.
- Opponent name
- Novo Nordisk A/S
Sanofi-Aventis Deutschland GmbH - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Main request and auxiliary requests 1 to 3: added subject-matter (yes)
Auxiliary request 4: added subject-matter (no), sufficiency of disclosure (yes), novelty (yes), inventive step (yes) - Catchword
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of auxiliary request 4 filed on 20 April 2012 and a description and figures to be adapted thereto.